EPZM - Epizyme - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Epizyme's activity chart (see below) currently has 92 price targets and 79 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 56.61% of the time, taking 438.64 days on average.

Most recent stock forecast was given by from TD COWEN on 28-Jun-2022. First documented stock forecast 12-Sep-2014.

Best performing analysts who are covering EPZM - Epizyme:

Andrew Fein David Nierengarten Leah Rush Cann Michael Yee Peter Lawson

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Apr-2021

$1.5

$12

4 years 4 months 24 days ago
(28-Jun-2022)

1/3 (33.33%)

$0.02 (1.35%)

38

Hold Since 28-Jun-2022

$1.5

4 years 4 months 24 days ago
(28-Jun-2022)

2/4 (50%)

$0.02 (1.35%)

161

Buy Since 24-Apr-2018

$30

4 years 4 months 25 days ago
(27-Jun-2022)

2/5 (40%)

$12.54 (71.82%)

611

Buy Since 13-Jun-2019

4 years 5 months 18 days ago
(03-Jun-2022)

2/2 (100%)

$13 (108.33%)

808

Sell Since 10-Aug-2021

$5

5 years 3 months 11 days ago
(10-Aug-2021)

4/8 (50%)

$-0.5 (-9.09%)

70

Show more analysts

Please expand the browser size to see the chart

What is EPZM (Epizyme) average time for price targets to be met?

On average it took 439 days for the stock forecasts to be reached, with an average price target met ratio of 56.61%.

Which analyst most recently updated their price target on EPZM (Epizyme)?

Which analyst has the most public recommendations on EPZM (Epizyme)?

has 0 price targets and 0 ratings on EPZM

Which analyst is the currently most bullish on EPZM (Epizyme)?

Robyn Karnauskas with the highest potential upside of $27.53

Which analyst is the currently most reserved on EPZM (Epizyme)?

David Nierengarten with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?